Cover Image

Pathway‐Based Similarity Measurement to Quantify Transcriptomics Similarity Between Human Tissues and Preclinical Models

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Paarth Parekh, Jason Sherfey, Begum Alaybeyoglu, Murat Cirit
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sex and the Kidney Drug‐Metabolizing Enzymes and Transporters: Are Preclinical Drug Disposition Data Translatable to Humans?
by: Aarzoo Thakur, et al.
Published: (2024)

HIV Pharmacology Data Repository: Setting the New Information‐Sharing Standard for Clinical and Preclinical Pharmacokinetic Studies
by: Lauren A.R. Tompkins, et al.
Published: (2025)

Transcriptomic Profiles Associated with Experimental Placebo Effects in Chronic Pain
by: Luana Colloca, et al.
Published: (2024)

Exploring the Association Between Intra‐Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients
by: Amy Rieborn, et al.
Published: (2025)

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans
by: Guang Yang, et al.
Published: (2025)

Dose Selection for DuoBody®‐CD40x4‐1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data
by: Gaurav Bajaj, et al.
Published: (2025)

Dual Minimal Physiologically Based Pharmacokinetic Model of Tenofovir Alafenamide and Its Metabolites in Humans
by: Weihua Jiang, et al.
Published: (2025)

The Serotonin 2B (5‐ HT2B ) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression
by: Gia Han Le, et al.
Published: (2026)

Comparative Analysis of Post‐Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023
by: Diana Mandslay, et al.
Published: (2024)

The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway
by: Rajanikanth Madabushi, et al.
Published: (2024)

Regulatory Perspective Based on Survey of Relationship Between Biopharmaceutical Characteristics and Food Effects on Systemic Pharmacokinetics
by: Naoko Honma, et al.
Published: (2025)

RAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome‐Wide Association Studies
by: Shailja C. Shah, et al.
Published: (2025)

Modeling Supports Combinatorial Effects Between Pharmacological and Non‐Pharmacological Interventions to Prevent Opioid‐Induced Cardiac Arrest
by: Bradlee Thrasher, et al.
Published: (2026)

Oral and Intravenous Metronidazole Concentrations in Facial Artery Musculomucosal Flap, Buccal Submucosa, and Subcutaneous Tissue—A Randomized Clinical Microdialysis Study
by: Pelle Hanberg, et al.
Published: (2025)

Mechanistic Modeling of Spatial Heterogeneity of Drug Penetration and Exposure in the Human Central Nervous System and Brain Tumors
by: Jing Li, et al.
Published: (2024)

Regulatory Pathways for Qualification and Acceptance of Digital Health Technology‐Derived Clinical Trial Endpoints: Considerations for Sponsors
by: Jessie P. Bakker, et al.
Published: (2024)

Guided Sample Pooling in Human Mass Balance Studies: A Recommended Strategic Decision Framework
by: Filip Cuyckens, et al.
Published: (2025)

Use of PopPK and E‐R Analyses toward Explaining Causal Link Between ADAMTS13 in Recombinant vs. Plasma‐Based Therapies and Clinical Effects in cTTP
by: Munjal Patel, et al.
Published: (2025)

A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus
by: Gerald C. So, et al.
Published: (2024)

Population Genomics Insights into Pharmacogenomic Differentiation Between East Asians and Europeans
by: Sihan Chen, et al.
Published: (2026)

Hepatitis B In Silico Trials Capture Functional Cure, Indicate Mechanistic Pathways, and Suggest Prognostic Biomarker Signatures
by: Javiera Cortés‐Ríos, et al.
Published: (2025)

Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends
by: Jason Boer, et al.
Published: (2026)

An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer
by: Joseph Piscitelli, et al.
Published: (2025)

Partial Residual Plots as an Integrated Model Diagnostic Tool in Model‐Based Meta‐Analysis
by: John Maringwa, et al.
Published: (2024)

Assessment of Efficacy Evidence for Approvals of Novel Drugs in China Between 2018 and 2022
by: Yang Xu, et al.
Published: (2024)

Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia
by: Xiao Yu Cindy Zhang, et al.
Published: (2025)

A Novel Two‐Part Mixture Model for the Incidence and Time Course of Cytokine Release Syndrome After Elranatamab Dosing in Multiple Myeloma Patients
by: Donald Irby, et al.
Published: (2025)

Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
by: Peter N. Morcos, et al.
Published: (2024)

FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
by: Million A. Tegenge, et al.
Published: (2025)

A Review of Virtual Twins in Physiologically‐Based Pharmacokinetic Modeling and Simulation
by: Emily Mannix, et al.
Published: (2026)

Pharmacokinetic Modeling and Model‐Based Hypothesis Generation for Dose Optimization of Clonidine in Neonates With Neonatal Opioid Withdrawal Syndrome
by: Fei Tang, et al.
Published: (2024)

Effect of Dapagliflozin on Measured vs. Panel‐Estimated Glomerular Filtration Rate
by: Esben Iversen, et al.
Published: (2024)

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation
by: Yoo Jin Jang, et al.
Published: (2024)

Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions
by: Cornelius Cilliers, et al.
Published: (2024)

Drug–Drug Interaction Between Dihydroartemisinin–Piperaquine and Sulfadoxine‐Pyrimethamine During Malaria Chemoprevention in Pregnant Women
by: Norah Mwebaza, et al.
Published: (2024)

Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA‐Based Therapeutics Using a Mechanistic Physiologically‐Based Pharmacokinetic‐Pharmacodynamic Model
by: Annie Lumen, et al.
Published: (2024)

Model‐Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation
by: Katharina M. Götz, et al.
Published: (2025)

Divergent Paths, Convergent Goals: Institutional Experiments in Cell and Gene Therapy Regulation and Payment Between China and the United States
by: Jiajv Chen, et al.
Published: (2026)

Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
by: Jaehee Shim, et al.
Published: (2026)

Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes
by: Ola Nordqvist, et al.
Published: (2025)